Clinical Trial Update: SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SOX vs XELOX as adjuvant chemotherapy in stage III colorectal cancer; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SOX (SOX)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Colorectal Cancer Stage III, Adjuvant Chemotherapy | Phase 3 | Status: UNKNOWN